Leukotriene pathway genetics and pharmacogenetics in allergy
- 11 May 2009
- Vol. 64 (6), 823-839
- https://doi.org/10.1111/j.1398-9995.2009.02015.x
Abstract
Leukotrienes (LT) are biologically active lipid mediators known to be involved in allergic inflammation. Leukotrienes have been shown to mediate diverse features of allergic conditions including inflammatory cell chemotaxis/activation and smooth muscle contraction. Cysteinyl leukotrienes (LTC(4), LTD(4) and, LTE(4)) and the dihydroxy leukotriene LTB(4) are generated by a series of enzymes/proteins constituting the LT synthetic pathway or 5-lipoxygenase (5-LO) pathway. Their function is mediated by interacting with multiple receptors. Leukotriene receptor antagonists (LTRA) and LT synthesis inhibitors (LTSI) have shown clinical efficacy in asthma and more recently in allergic rhinitis. Despite growing knowledge of leukotriene biology, the molecular regulation of these inflammatory mediators remains to be fully understood. Genes encoding enzymes of the 5-LO pathway (i.e. ALOX5, LTC4S and LTA4H) and encoding for LT receptors (CYSLTR1/2 and LTB4R1/2) provide excellent candidates for disease susceptibility and severity; however, their role remains unclear. Preliminary data also suggest that 5-LO pathway/receptor gene polymorphism can predict patient responses to LTSI and LTRA; however, the exact mechanisms require elucidation. The aim of this review was to summarize the recent advances in the knowledge of these important mediators, focusing on genetic and pharmacogenetic aspects in the context of allergic phenotypes.Keywords
This publication has 149 references indexed in Scilit:
- Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptorsProceedings of the National Academy of Sciences of the United States of America, 2008
- Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoidsProstaglandins & Other Lipid Mediators, 2007
- The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptorThe EMBO Journal, 2006
- Japanese single nucleotide polymorphism database for 267 possible drug-related genesCancer Science, 2006
- Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumorsActa Pharmacologica Sinica, 2005
- Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthmaJournal of Allergy and Clinical Immunology, 2004
- A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da CunhaPharmacogenetics, 2003
- Leukotriene C4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthmaBritish Journal of Clinical Pharmacology, 2003
- The Molecular Characterization and Tissue Distribution of the Human Cysteinyl Leukotriene CysLT2 ReceptorBiochemical and Biophysical Research Communications, 2000
- Redistribution of 5-Lipoxygenase and Cytosolic Phospholipase A2 to the Nuclear Fraction upon Macrophage ActivationBiochemical and Biophysical Research Communications, 1993